Vanguard Group Inc Phio Pharmaceuticals Corp. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.33 - $0.58 $21,006 - $36,920	-63,656 Reduced 29.17%	154,536 $57,000
Q3 2022 Nov 14, 2022	SELL	$0.62 - $0.79 $49,462 - $63,025	-79,779 Reduced 26.77%	218,192 $125,000
Q2 2022 Aug 12, 2022	SELL	$0.64 - $2.35 $3,934 - $14,447	-6,148 Reduced 2.02%	297,971 $210,000
Q1 2022 May 13, 2022	BUY	$0.73 - $1.1 $14,046 - $21,166	19,242 Added 6.75%	304,119 $269,000
Q3 2021 Nov 12, 2021	BUY	$1.62 - $2.28 $13,471 - $18,960	8,316 Added 3.01%	284,877 $578,000

Q2 2021 Aug 13, 2021	BUY	$1.87 - $2.8 $517,169 - $774,370	276,561 New	276,561 $625,000

Ticker PHIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,658,700
Market Cap $9.42M
Description
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression of the checkpoint...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.